Magnolol as a promising multitarget agent for Alzheimer's disease: Evidence from a systematic evidence synthesis, network pharmacology, and molecular dynamics simulations
Phytomedicine · 2026-09 · 159 · 158586
DOI: 10.1016/j.phymed.2026.158586 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Yiying Qin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shengjing Hospital of China Medical University, No. 36 Sanhao street, Heping District, Shenyang, 110000, Liaoning, China. El…. Hauptthemen laut MEDLINE: Lignans, Alzheimer Disease, Biphenyl Compounds. Die Arbeit nennt 90 Literaturangaben. Gefördert von: Liaoning Provincial Natural Science Foundation.
Themen: Demenz
Abstract (Originalsprache)
OBJECTIVE This study provides systematic synthesis of therapeutic effects of magnolol (MN) in preclinical Alzheimer's disease (AD) models and integrates network pharmacology with molecular dynamics (MD) simulations to predict its core targets and binding stability. METHODS Systematic literature search was conducted in PubMed, CNKI, Wanfang, and Google Scholar up to January 1, 2026 following PRISMA guidelines. Network pharmacology, molecular docking, and 100 ns MD simulations were used to identify common targets, evaluate binding affinities, and assess complex stability. RESULTS Fourteen studies (seven in vivo, five in vitro, two combined) were included. MN consistently ameliorated cognitive deficits and neuropathology through antioxidant, anti-inflammatory, anti-apoptotic, and anti-acetylcholinesterase activities, while preserving mitochondrial and synaptic function. Network pharmacology identified 60 common targets; Protein-Protein Interaction (PPI) analysis revealed five hub genes: AKT1, MMP9, MMP2, ERBB2, and EGFR. Molecular docking showed binding energies below -4.0 kcal/mol for all five targets, and MD simulations confirmed stable binding, with the ERBB2-MN complex exhibiting the lowest root mean square deviation (RMSD) (1.2 Å) and favorable free energy landscape. Molecular Mechanics/Poisson-Boltzmann Surface Area (MM-PBSA) calculations further confirmed that magnolol exhibited binding affinities comparable to the reference co‑crystal ligands. Unlike prior reviews, this study uniquely combines systematic evidence synthesis with computational predictions, identifying ERBB2 as a novel stable target of MN. CONCLUSION MN exerts anti-AD effects via multi-pathway and multi-target regulation, with computational predictions aligning with experimental evidence, supporting MN as promising lead compound for AD drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shengjing Hospital of China Medical University, No. 36 Sanhao street, Heping District, Shenyang, 110000, Liaoning, China. Electronic address: 2819590497@qq.com.
- Department of Neurology, Shengjing Hospital of China Medical University, No. 36 Sanhao street, Heping District, Shenyang, 110000, Liaoning, China. Electronic address: dongxy@sj-hospital.org.
- Department of Infectious Diseases, Shengjing Hospital of China Medical University, No. 39 Huaxiang Road, Tiexi District, Shenyang, 110000, Liaoning, China. Electronic address: zhangchong_83@163.com.
- Department of Neurology, Shengjing Hospital of China Medical University, No. 36 Sanhao street, Heping District, Shenyang, 110000, Liaoning, China. Electronic address: 18940256567@163.com.
Förderung
- Liaoning Provincial Natural Science Foundation
Zitieren
APA
Qin, Y., Dong, X., Zhang, C., & Nao, J. (2026). Magnolol as a promising multitarget agent for Alzheimer's disease: Evidence from a systematic evidence synthesis, network pharmacology, and molecular dynamics simulations. Phytomedicine, 159, 158586. https://doi.org/10.1016/j.phymed.2026.158586
Vancouver
Qin Y, Dong X, Zhang C, Nao J. Magnolol as a promising multitarget agent for Alzheimer's disease: Evidence from a systematic evidence synthesis, network pharmacology, and molecular dynamics simulations. Phytomedicine. 2026;159:158586. doi:10.1016/j.phymed.2026.158586
BibTeX
@article{Qin2026,
author = {Qin, Yiying and Dong, Xiaoyu and Zhang, Chong and Nao, Jianfei},
title = {Magnolol as a promising multitarget agent for Alzheimer's disease: Evidence from a systematic evidence synthesis, network pharmacology, and molecular dynamics simulations},
journal = {Phytomedicine},
year = {2026},
volume = {159},
pages = {158586},
doi = {10.1016/j.phymed.2026.158586}
}
EUVIMED